Anna Z Pollack

Dr. Anna Z Pollack

Department of Global and Community Health, College of Health and Human Services, George Mason University, Fairfax, VA 22030, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2013 in Human Reproduction
Verified
Journal Article
Open access
PDF file
SMSunni Mumford
Sunni Mumford
SDSonya S. Dasharathy
Sonya S. Dasharathy
Anna Z PollackAnna Z Pollack
Anna Z Pollack
NPNeil J Perkins
Neil J Perkins
DMDonald R. Mattison
Donald R. Mattison
ESEnrique F. Schisterman
Enrique F. Schisterman
Do uric acid levels across the menstrual cycle show associations with endogenous estradiol (E2) and reproductive hormone concentrations in regularly menstruating women? Mean uric acid concentrations were highest during the follicular phase, and were inversely associated with E2 and progesterone, and positively associated with FSH. E2 may decrease serum levels of uric acid in post-menopausal women; however, the interplay between endogenous reproductive hormones and uric acid levels among regularly menstruating women has not been elucidated. The BioCycle study was a prospective cohort study conducted at the University at Buffalo research centre from 2005 to 2007, which followed healthy women for one (n = 9) or 2 (n = 250) menstrual cycle(s). Participants were healthy women aged 18–44 years. Hormones and uric acid were measured in serum eight times each cycle for up to two cycles. Marginal structural models with inverse probability of exposure weights were used to evaluate the associations between endogenous hormones and uric acid concentrations. Uric acid levels were observed to vary across the menstrual cycle, with the lowest levels observed during the luteal phase. Every log-unit increase in E2 was associated with a decrease in uric acid of 1.1% (β = −0.011; 95% confidence interval (CI): −0.019, −0.004; persistent-effects model), and for every log-unit increase in progesterone, uric acid decreased by ∼0.8% (β = −0.008; 95% CI: −0.012, −0.004; persistent-effects model). FSH was positively associated with uric acid concentrations, such that each log-unit increase was associated with a 1.6% increase in uric acid (β = 0.016; 95% CI: 0.005, 0.026; persistent-effects model). Progesterone and FSH were also associated with uric acid levels in acute-effects models. Of 509 cycles, 42 were anovulatory (8.3%). Higher uric acid levels were associated with increased odds of anovulation (odds ratio 2.39, 95% CI: 1.25, 4.56). The change in uric acid levels among this cohort of healthy women was modest, and analysis was limited to two menstrual cycles. The women in this study were healthy and regularly menstruating, and as such there were few women with high uric acid levels and anovulatory cycles. These findings demonstrate the importance of taking menstrual cycle phase into account when measuring uric acid in premenopausal women, and confirm the hypothesized beneficial lowering effects of endogenous E2 on uric acid levels. These findings suggest that there could be an underlying association affecting both sporadic anovulation and high uric acid levels among young, regularly menstruating women. Further studies are needed to confirm these findings and elucidate the connection between uric acid and reproductive and later cardiovascular health. This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (contract # HHSN275200403394C). No competing interests declared.

1 October 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
SMSunni Mumford
Sunni Mumford
ASAnne Z. Steiner
Anne Z. Steiner
Anna Z PollackAnna Z Pollack
Anna Z Pollack
NPNeil J Perkins
Neil J Perkins
AFAmanda C. Filiberto
Amanda C. Filiberto
ESEnrique F. Schisterman
Enrique F. Schisterman
Context: Associations between menstrual cycle length and chronic diseases are hypothesized to be due to differences in underlying hormonal patterns. Objective: The aim of the study was to evaluate the association between menstrual cycle length and the hormonal profile and anovulation. Design and Setting: We conducted a prospective cohort study at the University at Buffalo from 2005 to 2007. Participants: We recruited 259 healthy, regularly menstruating women aged 18–44 yr. Main Outcome Measures: Cycle length was observed for up to two cycles. Serum estradiol, progesterone, LH, and FSH were measured up to eight times per cycle for up to two cycles. Results: Women with short cycles (35 d), estradiol and LH peaks occurred on average about 3 d later, and FSH peaks about 1 d later compared to women with normal-length cycles. Both short and long cycles, compared with normal-length cycles, had an increased probability of anovulation. In general, per-cycle exposure to hormones was less in short cycles based on the area under the curve, although over time the cumulative exposure to estradiol would be greater for women with short cycles. Conclusions: Short ovulatory cycles were associated with higher follicular phase estradiol, an earlier rise in FSH, and an increased risk of anovulation. These results suggest that menstrual cycle length may be a relevant indicator of estradiol exposure and risk of anovulation among regularly cycling women.

1 August 2011 in Environmental Health Perspectives
Verified
Journal Article
Open access
Anna Z PollackAnna Z Pollack
Anna Z Pollack
ESEnrique F. Schisterman
Enrique F. Schisterman
LGLynn R. Goldman
Lynn R. Goldman
SMSunni Mumford
Sunni Mumford
PAPaul S. Albert
Paul S. Albert
JWJean Wactawski-Wende
Jean Wactawski-Wende
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

1 November 2018 in Environment International
Verified
Journal Article
Closed access
Anna Z PollackAnna Z Pollack
Anna Z Pollack
SMSunni Mumford
Sunni Mumford
JKJenna R Krall
Jenna R Krall
ACAndrea E. Carmichael
Andrea E. Carmichael
LSLindsey A. Sjaarda
Lindsey A. Sjaarda
ESEnrique F. Schisterman
Enrique F. Schisterman

1 March 2016 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
SMSunni Mumford
Sunni Mumford
JCJorge E Chavarro
Jorge E Chavarro
Cuilin ZhangCuilin Zhang
Cuilin Zhang
NPNeil J Perkins
Neil J Perkins
LSLindsey A Sjaarda
Lindsey A Sjaarda
JWJean Wactawski-Wende
Jean Wactawski-Wende
Background: Emerging evidence suggests potential links between some dietary fatty acids and improved fertility, because specific fatty acids may affec

20 February 2012 in American Journal of Epidemiology
Verified
Journal Article
Closed access
SDS. S. Dasharathy
S. S. Dasharathy
SMSunni Mumford
Sunni Mumford
Anna Z PollackAnna Z Pollack
Anna Z Pollack
NPNeil J Perkins
Neil J Perkins
DMD. R. Mattison
D. R. Mattison
ESE. F. Schisterman
E. F. Schisterman
Menstrual bleeding patterns are considered relevant indicators of reproductive health, though few studies have evaluated patterns among regularly menstruating premenopausal women. The authors evaluated self-reported bleeding patterns, incidence of spotting, and associations with reproductive hormones among 201 women in the BioCycle Study (2005-2007) with 2 consecutive cycles. Bleeding patterns were assessed by using daily questionnaires and pictograms. Marginal structural models were used to evaluate associations between endogenous hormone concentrations and subsequent total reported blood loss and bleeding length by weighted linear mixed-effects models and weighted parametric survival analysis models. Women bled for a median of 5 days (standard deviation: 1.5) during menstruation, with heavier bleeding during the first 3 days. Only 4.8% of women experienced midcycle bleeding. Increased levels of follicle-stimulating hormone (β = 0.20, 95% confidence interval: 0.13, 0.27) and progesterone (β = 0.06, 95% confidence interval: 0.03, 0.09) throughout the cycle were associated with heavier menstrual bleeding, and higher follicle-stimulating hormone levels were associated with longer menses. Bleeding duration and volume were reduced after anovulatory compared with ovulatory cycles (geometric mean blood loss: 29.6 vs. 47.2 mL; P = 0.07). Study findings suggest that detailed characterizations of bleeding patterns may provide more insight than previously thought as noninvasive markers for endocrine status in a given cycle.